Effectiveness of chemotherapy in rhabdomyosarcoma: example of orbital primary

Author： Orbach Daniel Brisse Hervé Helfre Sylvie Freneaux Paul Husseini Khaled Aerts Isabelle Desjardins Laurence Fattet Sarah

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.12, 2003-12, pp. : 2165-2174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Choice of Cost-Effectiveness Measure in the Economic Evaluation of Cholesterol-Modifying Pharmacotherapy: An Illustrative Example Focusing on the Primary Prevention of Coronary Heart Disease in Canada

By Morris S.

PharmacoEconomics, Vol. 16, Iss. 2, 1999-08 ,pp. : 193-205

Adis International

Access to resources Recommend Favorite

Chemotherapy and Delivery in the Treatment of Primary Brain Tumors

Current Clinical Pharmacology, Vol. 2, Iss. 3, 2007-09 ,pp. : 197-211

Bentham Science Publishers

Access to resources Recommend Favorite

Primary prevention strategies for lipid-lowering: cost effectiveness

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 575, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Cost effectiveness of adjuvant chemotherapy a generation game?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 634, 2011-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Lenograstim + chemotherapy for small cell lung cancer: cost effectiveness "finely balanced"

Inpharma, Vol. 1, Iss. 1542, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite